1. Home
  2. NEHC vs MRKR Comparison

NEHC vs MRKR Comparison

Compare NEHC & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEHC
  • MRKR
  • Stock Information
  • Founded
  • NEHC 2023
  • MRKR N/A
  • Country
  • NEHC United States
  • MRKR United States
  • Employees
  • NEHC N/A
  • MRKR N/A
  • Industry
  • NEHC
  • MRKR Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEHC
  • MRKR Health Care
  • Exchange
  • NEHC NYSE
  • MRKR Nasdaq
  • Market Cap
  • NEHC 12.6M
  • MRKR 13.4M
  • IPO Year
  • NEHC N/A
  • MRKR N/A
  • Fundamental
  • Price
  • NEHC $0.67
  • MRKR $1.13
  • Analyst Decision
  • NEHC
  • MRKR Strong Buy
  • Analyst Count
  • NEHC 0
  • MRKR 3
  • Target Price
  • NEHC N/A
  • MRKR $13.17
  • AVG Volume (30 Days)
  • NEHC 192.6K
  • MRKR 39.2K
  • Earning Date
  • NEHC 01-01-0001
  • MRKR 05-27-2025
  • Dividend Yield
  • NEHC N/A
  • MRKR N/A
  • EPS Growth
  • NEHC N/A
  • MRKR N/A
  • EPS
  • NEHC N/A
  • MRKR N/A
  • Revenue
  • NEHC $532,780.00
  • MRKR $6,591,080.00
  • Revenue This Year
  • NEHC N/A
  • MRKR N/A
  • Revenue Next Year
  • NEHC N/A
  • MRKR N/A
  • P/E Ratio
  • NEHC N/A
  • MRKR N/A
  • Revenue Growth
  • NEHC N/A
  • MRKR 99.06
  • 52 Week Low
  • NEHC $0.68
  • MRKR $0.95
  • 52 Week High
  • NEHC $12.29
  • MRKR $5.99
  • Technical
  • Relative Strength Index (RSI)
  • NEHC N/A
  • MRKR 45.44
  • Support Level
  • NEHC N/A
  • MRKR $1.09
  • Resistance Level
  • NEHC N/A
  • MRKR $1.30
  • Average True Range (ATR)
  • NEHC 0.00
  • MRKR 0.09
  • MACD
  • NEHC 0.00
  • MRKR -0.00
  • Stochastic Oscillator
  • NEHC 0.00
  • MRKR 19.05

About NEHC NEW ERA HELIUM INC

New Era Helium Inc. is an exploration and production company that sources helium produced in association with the production of natural gas reserves in North America. The Company's primary operations include the exploration, development and production of helium, natural gas, oil and natural gas liquids. The Company owns and operates over 137,000 acres in Southeast New Mexico and has over 1.5 billion cubic feet of proved and probable helium reserves. Its producing oil and gas assets and non-producing acreage are located in Chaves County, New Mexico.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: